A Systematic Review and Meta-Analysis of Metabolic Syndrome Prevalence in Chinese Inpatients with Bipolar Disorder
Horm Metab Res DOI: 10.1055/a-1882-8423The aim of the work was to study the prevalence of metabolic syndrome in Chinese
patients with bipolar disorder. We searched Chinese literature related to the
study in prevalence of metabolic syndrome in bipolar disorder in Chinese
language, among which results such as comments, letters, reviews and case
reports were excluded. The prevalence of metabolic syndrome in bipolar disorder
was researched and discussed. A total of 1562 subjects were included in 11
studies. The prevalence of MetS in bipolar disorder was 33% (95%
CI=0.29–0.37), which was higher significantly than normal
control (10.82%), but similar to schizophrenia (31.59%). The
41.41% prevalence of MetS in male patients was higher significantly than
that in females (26.83%).The prevalence of MetS in BD treated by AAP was
47.54%, by MS was 19.19%, by MS+AAP was 40%.The
prevalence of MetS in BD treated by carbamazepine was 28.21%, by lithium
was 30%, by valproate was 21.71%, by clozepine was
51.43%, by olanzapine was 39.84%, by quetiapine was
39.44%, and by risperidone was 35%. The prevalence of MetS in
bipolar disorder was 33% (95% CI=0.29–0.37),
which was higher significantly than normal control (10.82%), but similar
to schizophrenia (31.59%). AAP and MS were the main one risks of MetS in
...
Source: Hormone and Metabolic Research - Category: Endocrinology Authors: Tao, Hejian Shen, Dong Zhou, Yong Sun, Fengli Li, Guorong Jin, Weidong Tags: Original Article: Endocrine Care Source Type: research
More News: Bipolar | Carbamazepine | China Health | Endocrinology | Hormones | Lithium | Mania | Metabolic Syndrome | Risperdal Consta | Schizophrenia | Seroquel | Study | Zyprexa